Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Nature. 2010 Mar 25;464(7288):529-35. doi: 10.1038/nature08983.
During the past century, treatments for the diseases of youth and middle age have helped raise life expectancy significantly. However, cognitive decline has emerged as one of the greatest health threats of old age, with nearly 50% of adults over the age of 85 afflicted with Alzheimer's disease. Developing therapeutic interventions for such conditions demands a greater understanding of the processes underlying normal and pathological brain ageing. Recent advances in the biology of ageing in model organisms, together with molecular and systems-level studies of the brain, are beginning to shed light on these mechanisms and their potential roles in cognitive decline.
在过去的一个世纪中,针对青少年和中年疾病的治疗方法极大地提高了预期寿命。然而,认知能力下降已成为老年时期最大的健康威胁之一,近 50%的 85 岁以上成年人患有阿尔茨海默病。为这些疾病开发治疗干预措施需要更深入地了解正常和病理性大脑衰老的过程。模型生物衰老生物学的最新进展,以及大脑的分子和系统水平研究,开始揭示这些机制及其在认知能力下降中的潜在作用。